MedTrace Logo

Evaluation of Oxidative Stress and Effect of Levothyroxine Treatment on Oxidative Stress in Hashimoto Disease

NCT01102205 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2013-06-13

No results posted yet for this study

Summary

Oxidative stress leads to or accompanies with numerous disease. Oxidative balance in subclinical hypothyroid or euthyroid state in Hashimoto disease are not known. Effect of levothyroxine therapy on oxidative balance are also not known in hashimoto disease.

Conditions

  • Hashimoto Disease

Sponsors & Collaborators

  • Vakif Gureba Training and Research Hospital

    lead OTHER

Principal Investigators

  • Mehmet ali Cikrikcioglu, MD · vakif gureba TRH,fatih,istanbul,turkey.specialist in internal medicine

Eligibility

Min Age
18 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2010-04-30
Completion
2010-10-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01102205 on ClinicalTrials.gov